For some reason I am not too concerned. Might have something to do with facts like the 29% ACV growth by portfolio expansion in both Australia and US. Churn rates have also reduced which is good to see.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
